Can Conventional ECG Technology Capture Fetal Cardiac Activity?
ConditionFetal Monitoring
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-55
SponsorUniversity of Washington
About this trial
This is a feasibility study for a new application for capturing fetal cardiac activity. The objective of this study is to determine if it is feasible to capture a fetal ECG signal using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR) device.
Eligibility criteria
Qualifiers
Singleton or twin pregnant women at 32 weeks gestation to full term after routine antepartum testing.
Disqualifiers
None.
Trial design
Treatments tested in this trial
- Holter Device
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Washington
Lead sponsor
Duke University
Collaborator
Source ClinicalTrials.gov